Brenda
Y. Hernandez, Ph.D., M.P.H. Assistant
Professor (
Researcher), Cancer Research Center of Hawaii, University
of Hawaii
M.P.H. (Epidemiology), Yale University
School of Medicine;
Ph.D. (Epidemiology), University of Hawaii at
Manoa
Dr.
Hernandez has been an Assistant Researcher in the Epidemiology
unit of the
Cancer Research Center since 2002 and Director of the Hawaii
Tumor Registry (HTR)
since 1999.
Her research interests include the molecular epidemiology
of cancer including both genetic and environmental factors
involved
in carcinogenesis. She is particularly interested in viruses
that are directly or indirectly involved in cancer development
and progression. Viruses and the human cancers with which they
are associated include human papillomavirus (HPV) and cervical
and other anogenital cancers, hepatitis B and C and hepatocellular
(liver) cancers, Epstein-Barr virus (EBV) and nasopharyngeal
cancers and certain lymphomas, and human herpesvirus 8 (HHV-8)
and Kaposi’s sarcoma.
These infectious agents influence the development of cancer
through varied mechanisms including interaction of viral genes
with host tumor-suppressor genes, integration of virus into host
DNA, and the establishment of persistent or latent infections.
Understanding the role of host factors is key to elucidating
the mechanism of viral carcinogenesis. Host immune responses
to infection include humoral and cellular mechanisms and function
to eliminate pathogens. Conditions resulting in immune suppression,
such as HIV-infection and organ transplantation, often increase
susceptibility to cancer development. Other host factors, such
as diet, alcohol intake, and cigarette smoking, may also influence
response to infection and subsequent neoplastic development.
Dr. Hernandez is presently a Co-Investigator in an NCI-funded
study of HPV persistence, Cohort Study of Diet and Duration
of HPV Infection. Along with study Principal Investigator, Dr. Marc
Goodman, she has been involved in this investigation involving
nearly 2,000 women on the island of Oahu during the past 5 years.
Dr. Hernandez runs the HPV testing laboratory that uses state-of-the
art DNA-based methods to detect the virus. HPV is a common sexually
transmitted pathogen affecting an estimated 25% of adult females
worldwide. Most HPV infections appear to clear after a relatively
short period of time with no clinical consequence. Some infected
women, however, develop a persistent infection with oncogenic
HPV types and it is these women who are at greatest risk for
developing cervical cancer. This study seeks to understand the
determinants of persistent HPV infection including host and viral
factors.
Dr. Hernandez is the Principal Investigator in a new NIH-funded
study, the Molecular Epidemiology and Natural History of
HPV infection in Heterosexual Men. Her study is part of the new
Pacific Center for Emerging Infectious Disease Research headed
by Dr.
Richard Yanagihara of the University of Hawaii. The high prevalence
of cervical HPV infection in women suggests that it is efficiently
transmitted from male sexual partners, but men have been comparatively
neglected in population-based research on HPV. Dr. Hernandez’s
new five-year study will establish a multiethnic cohort of
adult men who will be followed over 2 years. This study will
investigate
the molecular epidemiology and natural history of HPV infection
among heterosexual men including viral and host factors associated
with genital HPV infection. New knowledge gained from this
investigation may contribute to improved prevention and control
of this very
common sexually transmitted agent in both men and women and
subsequent reduction of HPV-associated sequelae.
The Hawaii Tumor Registry is a part of the Surveillance
Epidemiology and End Results (SEER) Program of the National
Cancer Institute.
The Registry provides complete cancer reporting for the entire
state and monitors trends in cancer incidence and mortality
over time. Dr. Hernandez has also been involved in the HTR’s
efforts to develop a tissue bank consisting of cancer tissue
specimens. Archived tissue specimens have been increasingly
recognized as a valuable research resource that can be used
to evaluate
nucleic acid and protein based measures of cancer etiology,
progression, and prognosis. Through techniques such as immunohistochemistry
and in situ hybridization, archival tissue can be used to detect
genetic polymorphisms and mutations, oncogene expression, as
well as environmental and infectious exposures. Dr. Hernandez
anticipates that the HTR’s tissue bank will provide a
rich research resource for local and national investigators.
Selected
Publications
Hernandez
BY, McDuffie K, Kamemoto L, Goodman MT. Diet and high-grade
premalignant lesions of the cervix: evidence of a protective
role for folate, riboflavin, thiamin, and vitamin B12. (In
press)
Hernandez
BY. Highlights of recent cancer incidence data in Hawaii. Hawaii
Med J 2003; 62:17-18.
Hernandez
BY. The Hawaii Tumor Registry: more than forty years of cancer
surveillance for the islands. Hawaii Med J 2002;61:53.
Goodman
MT, McDuffie K, Hernandez B, Wilkens LR, Bertram CC, Killeen
J, Le Marchand L, Selhub J, Murphy S, Donlon TA. Association
of methylenetetrahydrofolate reductase polymorphism C677T and
dietary folate with the risk of cervical dysplasia. Cancer
Epidemiol Biomarkers Prev 2001;10:1275-80.
Goodman
MT, McDuffie K, Hernandez B, Bertram CC, Wilkens LR, Guo C,
Seifried A, Killeen J, Le Marchand L.CYP1A1, GSTM1, and GSTT1
polymorphisms and the risk of cervical squamous intraepithelial
lesions in a multiethnic population. Gynecol Onc 2001;81:263-269.
Goodman
MT, McDuffie K, Hernandez B, Hankin JH, Wilkens LR, Franke
AA, Kolonel LN, Kuypers J, Kiviat N, Bertram CC, Kessel B,
Sunoo C, Nakamura J, Killeen J. The association of plasma micronutrients
with the risk of cervical atypical squamous cells of undetermined
significance (ASCUS). Asian Pacific J Cancer Prev 2000;1:337-45.